Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel-releasing intrauterine device

International Journal of Gynecology and Obstetrics

Volumn 113, Issue 2, 2011, Pages 116-119

  Ferrero, Simone ^a   Tramalloni, Daniela ^a   Venturini, Pier Luigi ^a   Remorgida, Valentino ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Danazol; Endometriosis; Intrauterine device; Levonorgestrel; Rectovaginal endometriosis

Indexed keywords

DANAZOL; LEVONORGESTREL; NAPROXEN;

ACNE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; FEMALE; FOLLOW UP; HAIR DISEASE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; OILY HAIR; PAIN ASSESSMENT; PATIENT SATISFACTION; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; RECTOVAGINAL ENDOMETRIOSIS; SEBORRHEA; SIDE EFFECT; VAGINA DISEASE; VAGINAL IRRITATION; WEIGHT GAIN;

EID: 79953805276     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2010.11.015     Document Type: Article

References (20)

1. Fedele L, Bianchi S, Zanconato G, Portuese A, Raffaelli R. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril 2001;75(3):485-8. (Pubitemid 32175660)
2. Lockhat FB, Emembolu JO, Konje JC. The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease. Hum Reprod 2004;19(1):179-84. (Pubitemid 38072029)
3. Lockhat FB, Emembolu JO, Konje JC. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up. Hum Reprod 2005;20(3):789-93. (Pubitemid 40425510)
4. Petta CA, Ferriani RA, Abrão MS, Hassan D, Rosa E, Silva JC, et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005;20(7):1993-8. (Pubitemid 40932389)
5. Petta CA, Ferriani RA, Abrão MS, Hassan D, Rosa e Silva JC, Podgaec S, et al. A 3-year follow-up ofwomen with endometriosis and pelvic pain users of the levonorgestrelreleasing intrauterine system. Eur J Obstet Gynecol Reprod Biol 2009;143(2):128-9.
6. Ferreira RA, Vieira CS, Rosa-E-Silva JC, Rosa-e-Silva AC, Nogueira AA, Ferriani RA. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue. Contraception 2010;81(2):117-22.
7. de Sá Rosa e Silva AC, Rosa e Silva JC, Nogueira AA, Petta CA, Abrão MS, Ferriani RA. The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis. Fertil Steril 2006;86(3):742-4.
8. Vercellini P, Frontino G, De Giorgi O, Aimi G, Zaina B, Crosignani PG. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril 2003;80(2):305-9. (Pubitemid 36959787)
9. Abou-Setta AM, Al-Inany HG, Farquhar CM. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev 2006(4) CD005072.
10. Selak V, Farquhar C, Prentice A, Singla A. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2007(4) CD000068.
11. Buttram Jr VC, Reiter RC, Ward S. Treatment of endometriosis with danazol: report of a 6-year prospective study. Fertil Steril 1985;43(3):353-60. (Pubitemid 15111119)
12. Igarashi M, Iizuka M, Abe Y, Ibuki Y. Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis. Hum Reprod 1998;13(7):1952-6.
13. Razzi S, Luisi S, Calonaci F, Altomare A, Bocchi C, Petraglia F. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Fertil Steril 2007;88(4):789-94. (Pubitemid 47498381)
14. Mizutani T, Nishiyama S, Amakawa I, Watanabe A, Nakamuro K, Terada N. Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository. Fertil Steril 1995;63(6):1184-9.
15. Luisi S, Razzi S, Lazzeri L, Bocchi C, Severi FM, Petraglia F. Efficacy of vaginal danazol treatment in women with menorrhagia during fertile age. Fertil Steril 2009;92(4):1351-4.
16. Menada MV, Remorgida V, Abbamonte LH, Fulcheri E, Ragni N, Ferrero S. Transvaginal ultrasonography combined with water-contrast in the rectum in the diagnosis of rectovaginal endometriosis infiltrating the bowel. Fertil Steril 2008;89(3):699-700. (Pubitemid 351335055)
17. Valenzano Menada M, Remorgida V, Abbamonte LH, Nicoletti A, Ragni N, Ferrero S. Does transvaginal ultrasonography combined with water-contrast in the rectum aid in the diagnosis of rectovaginal endometriosis infiltrating the bowel? Hum Reprod 2008;23(5):1069-75.
18. Biberoglu KO, Behrman SJ. Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness. Am J Obstet Gynecol 1981;139(6):645-54. (Pubitemid 11126195)
19. Practice Committee of American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil Steril 2008;90(5 Suppl):S260-9.
20. Ferrero S, Remorgida V, Venturini PL. Current pharmacotherapy for endometriosis. Expert Opin Pharmacother 2010;11(7):1123-34.